Proteomics Market Research
Key factors driving the growth of proteomics market include technological advancements such as mass spectrometry & protein microarrays and the need for high-throughput analysis to study complex interactions within proteome. In addition, the increasing acceptance for targeted and precision medicine is also contributing to the growth of proteomics solutions in the global market owing to the growing prevalence of chronic conditions such as cancer and cardiovascular diseases.
As per the report, the “proteomics market” was valued at USD 32.8 Billion in 2023 and is expected to reach USD 161.9 Billion by 2035, at a CAGR of 14.2% from 2024 to 2035.
Download Sample of The Report on Proteomics Market 2035- https://www.alliedmarketresearch.com/request-sample/1677
The field of proteomics refers to the systematic study of proteins in a biological context. While genomics looks at the complete set of an organism’s genetic material, proteomics investigates the rich and complex world of proteins, where functional activity happens inside cells. It implies the megastudy of protein construction, function and interactions attempting to decipher their role inside biological mechanisms in addition to pathological conditions. Mass spectrometry and protein microarrays, among other methods and bioinformatics tools, are used in proteomics to identify, quantify, and characterize the proteins that exist within a cell, tissue or organism.
The field of proteomics investigates the entire set of proteins expressed in a biological system, providing important information about cellular function, protein-protein interactions, and disease mechanisms. Proteomics has possible to be a powerful tool for biomarker discovery, drug development, and personalized medicine in the healthcare industry. Proteomics allows for the identification of biomarkers for disease at an early stage through its study of protein profiles in CDs, blood or other biofluids. In addition, it allows to build targeted therapies in order to understand the underlying molecular pathways of various diseases.
2023 Recession Impact Analysis
The proteomics market was significantly affected by the global recession.
Impact of the research and development activities in proteomics market has been hindered by an economic uncertainty.
Nevertheless, due to increased use of proteomics across chronic diseases treatment and drug discovery & development processes, the market is projected grow in long-term.
Have a Question? Connect with our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/1677
Reagents segment to continue dominating the market throughout the forecast period
By component, the reagent segment contributed to the highest market share in 2023 and will maintain popularity throughout the forecast period with more than three-fourths of proteomics market revenue being shared by this sub-segment, due to high usage of reagents for each every laboratory research work of proteomics.
Drug discovery segment to hold its dominance over the forecast period.
Based on application, the drug discovery segment captured the largest proteomics market share in 2023, contributing to more than half of the overall revenues. This is ascribed to the extensive adoption of proteomics for the assessment of drug candidate across a variety of parameters including safety profile, efficacy and toxicology in the preclinical trials.
For Purchase Enquiry – https://www.alliedmarketresearch.com/purchase-enquiry/1677
North America to continue dominating the landscape during the forecast period.
Globally, North America contributed to the highest market share in 2023, accounting for more than two-fifths of total proteomics market revenue. This is owing to the established healthcare framework and increase in case of chronic diseases. However, Asia-Pacific is predicted to yield a significant CAGR over the forecast timeline due developing pharmaceutical industries in these regions.
Leading Market Players:
Bio-Rad Laboratories Inc
Thermo Fisher Scientific Inc
Danaher Corporation
Bruker Corporation
Waters Corporation
Perkin Elmer Inc
Horiba Ltd.
Merck KGaA
Agilent Technologies Inc
Li-Cor Inc
Other Trending Reports in Life Science Domain
How Big Is the Pharmaceutical Primary Packaging Label Market by 2032? Size, Share & CAGR Analysis
Hepatitis Therapeutics Market Size: $19.17 Billion by 2030 | 3.1% CAGR Growth
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
